+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Melanoma"

Paranasal Sinus Cancer Global Market Report 2025 - Product Thumbnail Image

Paranasal Sinus Cancer Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
From
Vulvar Cancer Global Market Report 2025 - Product Thumbnail Image

Vulvar Cancer Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Uveal Neoplasms Global Market Report 2025 - Product Thumbnail Image

Uveal Neoplasms Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
Advanced Melanoma Global Market Report 2025 - Product Thumbnail Image

Advanced Melanoma Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
From
From
Prostate Cancer - Competitive landscape, 2024 - Product Thumbnail Image

Prostate Cancer - Competitive landscape, 2024

  • Clinical Trials
  • November 2024
  • 450 Pages
  • Global
From
From
Pipeline of Her3-Targeted Immunotherapies - Product Thumbnail Image

Pipeline of Her3-Targeted Immunotherapies

  • Report
  • February 2026
  • Global
From
Neoplasia and Fertility - Product Thumbnail Image

Neoplasia and Fertility

  • Book
  • September 2022
From
Loading Indicator

Melanoma is a type of cancer that affects the skin and is the most serious form of skin cancer. It is caused by the uncontrolled growth of pigment-producing cells, known as melanocytes. Melanoma is the fifth most common cancer in the United States, with an estimated 87,110 new cases in 2020. It is also the leading cause of death from skin disease. The melanoma market within the oncology space is a rapidly growing segment, driven by the increasing prevalence of the disease and the development of new treatments. The market is expected to be driven by the increasing adoption of targeted therapies, immunotherapies, and combination therapies. Additionally, the increasing focus on personalized medicine and the development of novel drug delivery systems are expected to drive the market. Some of the key players in the melanoma market include Bristol-Myers Squibb, Merck & Co., Novartis, Roche, Pfizer, and Eli Lilly. Show Less Read more